Virus-host Interactions during Hepatitis C Virus Entry-Implications for Pathogenesis and Novel Treatment Approaches

被引:1
|
作者
Joachim Lupberger
Mirjam B. Zeisel
Anita Haberstroh
Eva K. Schnober
Sophie Krieger
Eric Soulier
Christine Thumann
Cathy Royer
Samira Fafi-Kremer
Catherine Schuster
Franoise Stoll-Keller
Hubert E. Blum
Thomas F. Baumert
机构
[1] F-67000 Strasbourg France
[2] F-67000 Strasbourg France Service d’Hépatogastroentérologie H?pitaux Universitaires de Strasbourg Strasbourg France Department of Medicine II University of Freiburg Germany
[3] Inserm U748 H?pitaux Universitaires de Strasbourg Université Louis Pasteur 3 Rue Koeberle Department of Medicine II University of Freiburg Department of Medicine II University of Freiburg
[4] Germany
[5] Inserm U748 H?pitaux Universitaires de Strasbourg Université Louis Pasteur 3 Rue Koeberle
关键词
Hepatitis C virus; Viral entry; Entry inhibitor; Neutralizing antibodies;
D O I
暂无
中图分类号
R512.6 [病毒性肝炎];
学科分类号
100401 ;
摘要
Hepatitis C virus (HCV) is a member of the Flaviviridae family and causes acute and chronic hepatitis. Chronic HCV infection may result in severe liver damage including liver cirrhosis and hepatocellular carcinoma. The liver is the primary target organ of HCV, and the hepatocyte is its primary target cell. Attachment of the virus to the cell surface followed by viral entry is the first step in a cascade of interactions between the virus and the target cell that is required for successful entry into the cell and initiation of infection. This step is an important determinant of tissue tropism and pathogenesis; it thus represents a major target for antiviral host cell responses, such as antibody-mediated virus neutralization. Following the development of novel cell culture models for HCV infection our understanding of the HCV entry process and mechanisms of virus neutralization has been markedly advanced. In this review we summarize recent developments in the molecular biology of viral entry and its impact on pathogenesis of HCV infection, development of novel preventive and therapeutic antiviral strategies.
引用
收藏
页码:124 / 131
页数:8
相关论文
共 50 条
  • [31] Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals
    Che C. Colpitts
    Thomas F. Baumert
    Hepatology International, 2016, 10 : 741 - 748
  • [32] Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals
    Colpitts, Che C.
    Baumert, Thomas F.
    HEPATOLOGY INTERNATIONAL, 2016, 10 (05) : 741 - 748
  • [33] Hepatitis C Virus - Proteins, Diagnosis, Treatment and New Approaches for Vaccine Development
    Keyvani, Hossein
    Fazlalipour, Mehdi
    Monavari, Seyed Hamid Reza
    Mollaie, Hamid Reza
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (12) : 5917 - 5935
  • [34] Hepatitis C virus infection and thyroid autoimmune disorders: A model of interactions between the host and the environment
    Pastore, Francesca
    Martocchia, Antonio
    Stefanelli, Manuela
    Prunas, Pietro
    Giordano, Stefania
    Toussan, Lavinia
    Devito, Antonio
    Falaschi, Paolo
    WORLD JOURNAL OF HEPATOLOGY, 2016, 8 (02) : 83 - 91
  • [35] Hepatitis C virus infection and thyroid autoimmune disorders:A model of interactions between the host and the environment
    Francesca Pastore
    Antonio Martocchia
    Manuela Stefanelli
    Pietro Prunas
    Stefania Giordano
    Lavinia Toussan
    Antonio Devito
    Paolo Falaschi
    World Journal of Hepatology, 2016, (02) : 83 - 91
  • [36] Interactions between the Hepatitis C Virus Nonstructural 2 Protein and Host Adaptor Proteins 1 and 4 Orchestrate Virus Release
    Xiao, Fei
    Wang, Stanley
    Barouch-Bentov, Rina
    Neveu, Gregory
    Pu, Szuyuan
    Beer, Melanie
    Schor, Stanford
    Kumar, Sathish
    Nicolaescu, Vlad
    Lindenbach, Brett D.
    Randall, Glenn
    Einav, Shirit
    MBIO, 2018, 9 (02):
  • [37] Cyclophilins and Their Roles in Hepatitis C Virus and Flavivirus Infections: Perspectives for Novel Antiviral Approaches
    Gallardo-Flores, Carla E.
    Colpitts, Che C.
    PATHOGENS, 2021, 10 (07):
  • [38] Intrinsic disorder mediates hepatitis C virus core-host cell protein interactions
    Dolan, Patrick T.
    Roth, Andrew P.
    Xue, Bin
    Sun, Ren
    Dunker, A. Keith
    Uversky, Vladimir N.
    LaCount, Douglas J.
    PROTEIN SCIENCE, 2015, 24 (02) : 221 - 235
  • [39] EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
    Lupberger, Joachim
    Zeisel, Mirjam B.
    Xiao, Fei
    Thumann, Christine
    Fofana, Isabel
    Zona, Laetitia
    Davis, Christopher
    Mee, Christopher J.
    Turek, Marine
    Gorke, Sebastian
    Royer, Cathy
    Fischer, Benoit
    Zahid, Muhammad N.
    Lavillette, Dimitri
    Fresquet, Judith
    Cosset, Francois-Loic
    Rothenberg, S. Michael
    Pietschmann, Thomas
    Patel, Arvind H.
    Pessaux, Patrick
    Doffoel, Michel
    Raffelsberger, Wolfgang
    Poch, Olivier
    McKeating, Jane A.
    Brino, Laurent
    Baumert, Thomas F.
    NATURE MEDICINE, 2011, 17 (05) : 589 - U109
  • [40] Integrative Transcriptomics and Proteomics Analysis Provide a Deep Insight Into Bovine Viral Diarrhea Virus-Host Interactions During BVDV Infection
    Ma, Yingying
    Wang, Li
    Jiang, Xiaoxia
    Yao, Xin
    Huang, Xinning
    Zhou, Kun
    Yang, Yaqi
    Wang, Yixin
    Sun, Xiaobo
    Guan, Xueting
    Xu, Yigang
    FRONTIERS IN IMMUNOLOGY, 2022, 13